Evolus, Inc. has appointed Christos Monovoukas as Senior Vice President, Corporate Development, effective February 28, 2022. Monovoukas will join Evolus' Leadership Team reporting to CEO David Moatazedi and support the company's strategic goals and growth strategy. Monovoukas brings more than 20 years of leadership experience in business development, mergers and acquisitions, venture investing, corporate strategy and operations across a number of healthcare companies.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.93 USD | +2.54% | +3.36% | +22.79% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.79% | 810M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- EOLS Stock
- News Evolus, Inc.
- Evolus, Inc. Appoints Christos Monovoukas as Senior Vice President of Corporate Development